Artificial Intelligence in Drug Discovery for Rare Diseases

Rare diseases affect a significant portion of the global population despite their individual rarity, yet therapeutic development remains limited due to economic and scientific constraints. Artificial intelligence (AI) has emerged as a transformative approach in pharmaceutical research, enabling the analysis of large-scale biological datasets and accelerating the identification of potential drug candidates. This study explores the role of machine learning and deep learning techniques in rare disease drug discovery. AI-driven models facilitate drug-target interaction prediction, molecular optimization, and drug repurposing, significantly reducing time and cost. The paper also discusses methodological frameworks, applications, challenges, and future directions of AI integration in pharmaceutical research. The findings indicate that AI has the potential to revolutionize rare disease treatment by improving efficiency, accuracy, and accessibility.

Keywords

Artificial intelligence; drug discovery; rare diseases; machine learning; deep learning; bioinformatics.

Downloads

PDF JATS XML

References

1. Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018). The rise of deep learning in drug discovery. Drug Discovery Today, 23(6), 1241–1250. [Google Scholar] [Crossref]

2. Ekins, S. (2019). Exploiting machine learning for drug discovery. Nature Materials, 18(5), 435–436. [Google Scholar] [Crossref]

3. Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., … Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596(7873), 583–589. [Google Scholar] [Crossref]

4. Mak, K. K., & Pichika, M. R. (2019). Artificial intelligence in drug development: Present status and future prospects. Drug Discovery Today, 24(3), 773–780. [Google Scholar] [Crossref]

5. Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021). Artificial intelligence in drug discovery and development. Drug Discovery Today, 26(1), 80–93. [Google Scholar] [Crossref]

6. Schneider, G. (2020). Automating drug discovery. Nature Reviews Drug Discovery, 19(6), 353–364. [Google Scholar] [Crossref]

7. Zhavoronkov, A. (2018). Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry. Nature Biotechnology, 36(11), 1038–1040. [Google Scholar] [Crossref]

8. Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., … Collins, J. J. (2020). A deep learning approach to antibiotic discovery. Cell, 180(4), 688–702. [Google Scholar] [Crossref]

9. Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., … Snowden, M. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463–477. [Google Scholar] [Crossref]

10. Altae-Tran, H., Ramsundar, B., Pappu, A. S., & Pande, V. (2017). Low data drug discovery with one-shot learning. ACS Central Science, 3(4), 283–293. [Google Scholar] [Crossref]

11. Segler, M. H. S., Preuss, M., & Waller, M. P. (2018). Planning chemical syntheses with deep neural networks. Nature, 555(7698), 604–610. [Google Scholar] [Crossref]

12. Chen, B., Butte, A. J., & Chen, Y. (2020). Artificial intelligence in drug discovery: Applications and techniques. Briefings in Bioinformatics, 21(3), 865–879. [Google Scholar] [Crossref]

13. Walters, W. P., & Murcko, M. (2020). Generative AI in medicinal chemistry. Nature Biotechnology, 38(2), 143–145. [Google Scholar] [Crossref]

14. Lo, Y. C., Rensi, S. E., Torng, W., & Altman, R. B. (2018). Machine learning in chemoinformatics and drug discovery. Drug Discovery Today, 23(8), 1538–1546. [Google Scholar] [Crossref]

15. Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2020). AI in medicinal chemistry. Future Medicinal Chemistry, 12(12), 1065–1079. [Google Scholar] [Crossref]

16. Gawehn, E., Hiss, J. A., & Schneider, G. (2016). Deep learning in drug discovery. Molecular Informatics, 35(1), 3–14. [Google Scholar] [Crossref]

17. Chen, Y., Li, L., & Zhang, Q. (2018). Drug-target interaction prediction using machine learning. Bioinformatics, 34(17), 289–296. [Google Scholar] [Crossref]

18. Zhou, H., Gao, M., & Skolnick, J. (2019). Artificial intelligence in precision medicine. Trends in Pharmacological Sciences, 40(3), 146–158. [Google Scholar] [Crossref]

19. Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., … Dean, J. (2019). A guide to deep learning in healthcare. Nature Medicine, 25(1), 24– 29. [Google Scholar] [Crossref]

20. Topol, E. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. [Google Scholar] [Crossref]

21. Schork, N. J. (2015). Personalized medicine: Time for one-person trials. Nature, 520(7549), 609–611. [Google Scholar] [Crossref]

22. Zhang, L., Tan, J., Han, D., & Zhu, H. (2021). From machine learning to deep learning in healthcare. Frontiers in Genetics, 12, 123–135. [Google Scholar] [Crossref]

23. Goodfellow, I., Bengio, Y., & Courville, A. (2016). Deep Learning. MIT Press. [Google Scholar] [Crossref]

24. LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436– 444. [Google Scholar] [Crossref]

25. Silver, D., Schrittwieser, J., Simonyan, K., Antonoglou, I., Huang, A., Guez, A., … Hassabis, D. (2017). Mastering the game of Go with deep neural networks. Nature, 529, 484–489. [Google Scholar] [Crossref]

26. Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., … Greene, C. S. (2018). Opportunities and obstacles for deep learning in biology. Journal of the Royal Society Interface, 15(141), 20170387. [Google Scholar] [Crossref]

27. Min, S., Lee, B., & Yoon, S. (2017). Deep learning in bioinformatics. Briefings in Bioinformatics, 18(5), 851–869. [Google Scholar] [Crossref]

28. Angermueller, C., Pärnamaa, T., Parts, L., & Stegle, O. (2016). Deep learning for computational biology. Molecular Systems Biology, 12(7), 878. [Google Scholar] [Crossref]

29. Senior, A. W., Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., … Hassabis, D. (2020). Improved protein structure prediction using deep learning. Nature, 577(7792), 706–710. [Google Scholar] [Crossref]

30. Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., … Aspuru-Guzik, A. (2019). Deep learning enables rapid identification of kinase inhibitors. Nature Biotechnology, 37(9), 1038–1040. [Google Scholar] [Crossref]

Artificial Intelligence in Drug Discovery for Rare Diseases

Authors

Article Information

Publication Timeline

Abstract

Keywords

Downloads

References

Metrics

Views & Downloads

Similar Articles